MedPath

Adverse Drug Reactions of Different Brands of Ceftazidime Injection

Phase 4
Conditions
Infection
Registration Number
NCT00173901
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Detailed Description

Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
536
Inclusion Criteria
  • patients in surgical intensive care unit who require ceftazidime treatment
Exclusion Criteria
  • less than 1 year old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The adverse drug reactions of ceftazidime
Secondary Outcome Measures
NameTimeMethod
The effectiveness of ceftazidime

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath